Literature DB >> 3383636

Myocardial sarcoidosis unresponsive to steroids. Treatment with cyclophosphamide.

S L Demeter1.   

Abstract

Sarcoidosis affecting the pleura, pericardium, and myocardium is described in a patient who demonstrated continued disease activity while on therapy with high-dose steroids. Cyclophosphamide was found to be highly effective in suppressing her disease over a period of six years.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3383636     DOI： 10.1378/chest.94.1.202

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


  17 in total

Review 1.  Management of Arrhythmias in Cardiac Sarcoidosis.

Authors:  David G Rosenthal; Paco E Bravo; Kristen K Patton; Zachary D Goldberger
Journal:  Clin Cardiol       Date:  2015-07-14       Impact factor: 2.882

2.  A Diagnostic and Therapeutic Approach to Arrhythmias in Cardiac Sarcoidosis.

Authors:  Brian A Houston; Carolyn Park; Monica Mukherjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-03

Review 3.  Cardiac sarcoidosis: diagnostic, prognostic, and therapeutic considerations.

Authors:  M Sekiguchi; Y Yazaki; M Isobe; M Hiroe
Journal:  Cardiovasc Drugs Ther       Date:  1996-11       Impact factor: 3.727

4.  Brazilian Society of Cardiology Guideline on Myocarditis - 2022.

Authors:  Marcelo Westerlund Montera; Fabiana G Marcondes-Braga; Marcus Vinícius Simões; Lídia Ana Zytynski Moura; Fabio Fernandes; Sandrigo Mangine; Amarino Carvalho de Oliveira Júnior; Aurea Lucia Alves de Azevedo Grippa de Souza; Bárbara Maria Ianni; Carlos Eduardo Rochitte; Claudio Tinoco Mesquita; Clerio F de Azevedo Filho; Dhayn Cassi de Almeida Freitas; Dirceu Thiago Pessoa de Melo; Edimar Alcides Bocchi; Estela Suzana Kleiman Horowitz; Evandro Tinoco Mesquita; Guilherme H Oliveira; Humberto Villacorta; João Manoel Rossi Neto; João Marcos Bemfica Barbosa; José Albuquerque de Figueiredo Neto; Louise Freire Luiz; Ludhmila Abrahão Hajjar; Luis Beck-da-Silva; Luiz Antonio de Almeida Campos; Luiz Cláudio Danzmann; Marcelo Imbroise Bittencourt; Marcelo Iorio Garcia; Monica Samuel Avila; Nadine Oliveira Clausell; Nilson Araujo de Oliveira; Odilson Marcos Silvestre; Olga Ferreira de Souza; Ricardo Mourilhe-Rocha; Roberto Kalil Filho; Sadeer G Al-Kindi; Salvador Rassi; Silvia Marinho Martins Alves; Silvia Moreira Ayub Ferreira; Stéphanie Itala Rizk; Tiago Azevedo Costa Mattos; Vitor Barzilai; Wolney de Andrade Martins; Heinz-Peter Schultheiss
Journal:  Arq Bras Cardiol       Date:  2022-07       Impact factor: 2.667

5.  Controversies in the Treatment of Cardiac Sarcoidosis.

Authors:  Ogugua Ndili Obi; Elyse E Lower; Robert P Baughman
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2022-06-29       Impact factor: 1.803

Review 6.  Cardiac involvement in sarcoidosis: evolving concepts in diagnosis and treatment.

Authors:  Joseph P Lynch; Jennifer Hwang; Jason Bradfield; Michael Fishbein; Kalyanam Shivkumar; Roderick Tung
Journal:  Semin Respir Crit Care Med       Date:  2014-07-09       Impact factor: 3.119

Review 7.  Atrial Fibrillation in Cardiac Sarcoidosis.

Authors:  Davendra Mehta; Jonathan M Willner; Philippe R Akhrass
Journal:  J Atr Fibrillation       Date:  2015-12-31

8.  Cyclophosphamide therapy of idiopathic hepatic granulomatosis.

Authors:  G F Longstreth; R A Bender
Journal:  Dig Dis Sci       Date:  1989-10       Impact factor: 3.199

Review 9.  Immunosuppressive and cytotoxic therapy for pulmonary sarcoidosis.

Authors:  S Paramothayan; T J Lasserson; E H Walters
Journal:  Cochrane Database Syst Rev       Date:  2006-07-19

Review 10.  Current and emerging pharmacological treatments for sarcoidosis: a review.

Authors:  Scott H Beegle; Kerry Barba; Romel Gobunsuy; Marc A Judson
Journal:  Drug Des Devel Ther       Date:  2013-04-12       Impact factor: 4.162
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.